China Universal Asset Management Co., Ltd. Alpine Immune Sciences, Inc. Transaction History

China Universal Asset Management Co., Ltd.

$893 Million
Q3 2024

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 29, 2024	BUY	$17.75 - $41.6 $104,849 - $245,731	5,907 Added 87.86%	12,630 $501,000
Q4 2023 May 21, 2024	SELL	$8.54 - $20.22 $50,445 - $119,439	-5,907 Reduced 46.77%	6,723 $128,000
Q4 2023 Jan 23, 2024	BUY	$8.54 - $20.22 $46,577 - $110,279	5,454 Added 429.79%	6,723 $128,000
Q3 2023 May 21, 2024	BUY	$10.13 - $13.98 $6,483 - $8,947	640 Added 101.75%	1,269 $14,000
Q3 2023 Oct 30, 2023	BUY	$10.13 - $13.98 $6,483 - $8,947	640 Added 101.75%	1,269 $15,000
Q2 2023 May 21, 2024	BUY	$6.84 - $11.91 $41 - $71	6 Added 0.96%	629 $6,000
Q2 2023 Jul 27, 2023	BUY	$6.84 - $11.91 $41 - $71	6 Added 0.96%	629 $6,000
Q1 2023 May 21, 2024	BUY	$7.0 - $8.75 $1,092 - $1,365	156 Added 33.4%	623 $4,000
Q1 2023 Apr 27, 2023	BUY	$7.0 - $8.75 $1,092 - $1,365	156 Added 33.4%	623 $5,000
Q4 2022 May 21, 2024	SELL	$5.45 - $7.35 $66,288 - $89,398	-12,163 Reduced 96.3%	467 $3,000
Q4 2022 Jan 31, 2023	BUY	$5.45 - $7.35 $991 - $1,337	182 Added 63.86%	467 $3,000
Q3 2022 Oct 21, 2022	BUY	$6.89 - $9.39 $1,963 - $2,676	285 New	285 $2,000

Others Institutions Holding ALPN

# of Institutions

Shares Held

56.2K

Call Options Held

Put Options Held

View Full List

About ALPINE IMMUNE SCIENCES, INC.

Ticker ALPN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,006,700
Description
Alpine Immune Sciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of protein-based immunotherapies for the treatment of cancer, autoimmune/inflammatory disorders, and other diseases. Its product pipeline includes ALPN-101, an inducible T cell costimulator (ICOS)/cluster of differentiation 28 (CD28...

More about ALPN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of China Universal Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on China Universal Asset Management Co., Ltd. with notifications on news.

Account